Hedge Fund - Biotechnology Value Fund / BVF Inc
Kura Oncology Inc. (KURA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $51,177,251 | 2.09% | 7,754,129 | $7.79 |
| 2 | 2024 - Q4 (2024-12-31) | $22,362,655 | 0.75% | 2,567,469 | $14.39 |
| 3 | 2024 - Q3 (2024-09-30) | $65,884,210 | 1.92% | 3,371,761 | $20.26 |
| 4 | 2024 - Q2 (2024-06-30) | $84,049,142 | 2.35% | 4,082,037 | $20.56 |
| 5 | 2024 - Q1 (2024-03-31) | $102,091,630 | 2.8% | 4,786,293 | $19.44 |
| 6 | 2023 - Q4 (2023-12-31) | $106,027,019 | 2.65% | 7,373,228 | $9.83 |
| 7 | 2023 - Q3 (2023-09-30) | $61,386,565 | 1.65% | 6,730,983 | $10.15 |
| 8 | 2023 - Q2 (2023-06-30) | $71,213,800 | 1.98% | 6,730,983 | $11.83 |
| 9 | 2023 - Q1 (2023-03-31) | $82,319,922 | 3% | 6,730,983 | $12.48 |
| 10 | 2022 - Q4 (2022-12-31) | $47,170,199 | 1.99% | 3,800,983 | $14.54 |
| 11 | 2022 - Q3 (2022-09-30) | $43,764,000 | 1.8% | 3,203,783 | $15.42 |
| 12 | 2022 - Q2 (2022-06-30) | $58,725,000 | 2.83% | 3,203,783 | $14.38 |
| 13 | 2022 - Q1 (2022-03-31) | $51,517,000 | 2.06% | 3,203,783 | $14.44 |
| 14 | 2021 - Q4 (2021-12-31) | $28,899,000 | 1.04% | 2,064,212 | $16.20 |
| 15 | 2021 - Q3 (2021-09-30) | $30,626,000 | 1.19% | 1,635,112 | $18.84 |
| 16 | 2021 - Q2 (2021-06-30) | $34,092,000 | 1.27% | 1,635,112 | $24.83 |
| 17 | 2021 - Q1 (2021-03-31) | $46,225,000 | 1.73% | 1,635,112 | $31.64 |
| 18 | 2020 - Q4 (2020-12-31) | $40,691,000 | 1.6% | 1,245,912 | $35.14 |
| 19 | 2020 - Q3 (2020-09-30) | $45,626,000 | 2.48% | 1,489,112 | $22.08 |
| 20 | 2020 - Q2 (2020-06-30) | $45,247,000 | 2.78% | 2,775,882 | $14.42 |
| 21 | 2020 - Q1 (2020-03-31) | $24,225,000 | 2.25% | 2,434,696 | $11.45 |
| 22 | 2019 - Q4 (2019-12-31) | $27,476,000 | 2.08% | 1,998,276 | $14.82 |
| 23 | 2019 - Q3 (2019-09-30) | $30,314,000 | 3.18% | 1,998,276 | $17.80 |
| 24 | 2019 - Q2 (2019-06-30) | $43,399,000 | 4.73% | 2,204,119 | $16.60 |
| 25 | 2019 - Q1 (2019-03-31) | $41,395,000 | 4.63% | 2,495,156 | $15.41 |
| 26 | 2018 - Q4 (2018-12-31) | $38,963,000 | 5.09% | 2,775,156 | $13.25 |
| 27 | 2018 - Q3 (2018-09-30) | $35,277,000 | 3.09% | 2,015,856 | $19.17 |
| 28 | 2018 - Q2 (2018-06-30) | $37,444,000 | 3.65% | 2,057,346 | $16.94 |
| 29 | 2018 - Q1 (2018-03-31) | $25,385,000 | 2.57% | 1,353,846 | $19.47 |
| 30 | 2017 - Q4 (2017-12-31) | $20,714,000 | 2.49% | 1,353,846 | $14.74 |
| 31 | 2017 - Q3 (2017-09-30) | $20,240,000 | 2.57% | 1,353,846 | $9.39 |
The displayed share prices are average quarterly stock market prices.